Alx Oncology Holdings (ALXO) Share-based Compensation (QoQ) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Alx Oncology Holdings | 189.80 Mn | 49.48 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.28% |
| Dec 31, 2025 | 7.34% |
| Sep 30, 2025 | 18.02% |
| Jun 30, 2025 | -59.05% |
| Mar 31, 2025 | -10.96% |
| Dec 31, 2024 | -15.74% |
| Sep 30, 2024 | -4.14% |
| Jun 30, 2024 | 3.14% |
| Mar 31, 2024 | 4.61% |
| Dec 31, 2023 | -3.49% |
| Sep 30, 2023 | 11.66% |
| Jun 30, 2023 | -1.79% |
| Mar 31, 2023 | 0.89% |
| Dec 31, 2022 | 1.42% |
| Sep 30, 2022 | 6.36% |
| Jun 30, 2022 | 6.09% |
| Mar 31, 2022 | -3.25% |
| Dec 31, 2021 | 35.67% |
| Sep 30, 2021 | 87.35% |
| Jun 30, 2021 | 24.28% |
| Mar 31, 2021 | 3.27% |
| Dec 31, 2020 | 152.98% |
| Sep 30, 2020 | -75.85% |
| Jun 30, 2020 | 1,789.40% |
| Mar 31, 2020 | 101.33% |
| Dec 31, 2019 | -12.79% |
| Sep 30, 2019 | 43.33% |